Tolterodine
Showing 1 - 25 of 135
Female Patients With Overactive Bladder Syndrome Trial in Banqiao (tolterodine, mirabegron, tolterodine , mirabegron)
Not yet recruiting
- Female Patients With Overactive Bladder Syndrome
- tolterodine
- +2 more
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jul 13, 2023
Overactive Bladder, Obstructive Sleep Apnea, Overactive Bladder Syndrome Trial in Van (Tolterodine Tartrate 4 MG, Continuous
Completed
- Overactive Bladder
- +2 more
- Tolterodine Tartrate 4 MG
- Continuous positive airway pressure therapy (CPAP)
-
Van, TurkeyYuzuncu Yıl University
Feb 10, 2022
Urinary Incontinence, Urgency Urinary Trial in Boston (Oxybutynin, Solifenacin, Tolterodine, Sanctura or Toviaz)
Completed
- Urinary Incontinence
- Urgency Urinary
- Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
-
Boston, MassachusettsBrigham & Women's Hospital
Oct 21, 2022
Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,
Recruiting
- Urinary Incontinence, Urge
- +5 more
- Tolterodine Tartrate ER
- +2 more
-
Palo Alto, California
- +1 more
Dec 7, 2022
Urinary Bladder, Overactive Trial in Singapore (tolterodine tartrate)
Completed
- Urinary Bladder, Overactive
- tolterodine tartrate
-
Singapore, SingaporePfizer Investigational Site
Jan 26, 2021
Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence Trial in Cairo
Completed
- Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence
- Low dose tadalafil 5 mg
- +2 more
-
Cairo, EgyptSamer Morsy
Aug 11, 2022
Urinary Incontinence Trial in China (tolterodine extended release capsule)
Completed
- Urinary Incontinence
- tolterodine extended release capsule
-
Beijing, Beijing, China
- +6 more
Jan 26, 2021
Overactive Bladder Trial in San Francisco (Tolterodine ER, Placebo)
Terminated
- Overactive Bladder
- Tolterodine ER
- Placebo
-
San Francisco, California
- +1 more
Jan 26, 2021
Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)
Recruiting
- Sjogren's Syndrome
- Overactive Bladder Syndrome
- mirabegron
- oxybutynin, tolterodine, solifenacin
-
Taichung, TaiwanChina Medical University Hospital
Aug 8, 2021
Urinary Incontinence Trial in United Kingdom (Tolterodine ER, Placebo)
Completed
- Urinary Incontinence
- Tolterodine ER
- Placebo
-
Blackburn, Lancashire, United Kingdom
- +10 more
Jan 26, 2021
Memory, Cognition Trial in United States (Tolterodine ER, Oxybutynin ER)
Completed
- Memory
- Cognition
- Tolterodine ER
- Oxybutynin ER
-
Tucson, Arizona
- +8 more
Jan 26, 2021
Overactive Bladder Trial in Zurich (Tolterodine, Filling cystometry, Intravesical neurostimulation)
Completed
- Overactive Bladder
- Tolterodine
- +2 more
-
Zurich, SwitzerlandPfizer Investigational Site
Jan 26, 2021
Urinary Incontinence Trial (tolterodine SR, overactive bladder)
Completed
- Urinary Incontinence
- tolterodine SR, overactive bladder
- (no location specified)
Jan 26, 2021
Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD)
Completed
- Urinary Incontinence
- Tolterodine ER 4 mg QD
- Tamsulosin 0.4 mg QD
-
Birmingham, Alabama
- +94 more
Jan 26, 2021
Overactive Bladder Trial in Irwon-dong, Gyeonggi-do, Seoul (Tolterodine, Tolterodine 6)
Completed
- Overactive Bladder
- Tolterodine
- Tolterodine 6
-
Irwon-dong, Seoul, Korea, Republic of
- +3 more
Nov 28, 2019
Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, OAB Patient Behavioral Training Material)
Completed
- Urinary Incontinence
- Tolterodine ER 4 mg QD
- OAB Patient Behavioral Training Material
-
Phoenix, Arizona
- +50 more
Jan 26, 2021
Urinary Incontinence Trial in United States (Tolterodine ER 4mg QD)
Completed
- Urinary Incontinence
- Tolterodine ER 4mg QD
-
Chandler, Arizona
- +57 more
Jan 26, 2021
Urinary Bladder, Overactive Trial in United States (tolterodine extended release)
Completed
- Urinary Bladder, Overactive
- tolterodine extended release
-
Birmingham, Alabama
- +95 more
Jan 26, 2021
Spinal Vascular Disorder Nos, Overactive Bladder Trial (surgery, sacral neuromodulation, botulinum toxin A injection)
Not yet recruiting
- Spinal Vascular Disorder Nos
- Overactive Bladder
- surgery
- +3 more
- (no location specified)
Apr 28, 2020
Overactive Bladder, Benign Prostatic Hyperplasia Trial in Seoul (doxazosin plus tolterodine SR)
Completed
- Overactive Bladder
- Benign Prostatic Hyperplasia
- doxazosin plus tolterodine SR
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 28, 2019
Ureteral Obstruction Trial in Madison (Tamsulosin, Tolterodine ER)
Completed
- Ureteral Obstruction
- Tamsulosin
- Tolterodine ER
-
Madison, WisconsinUniversity of Wisconsin
Jun 20, 2019
Overactive Bladder in Taiwan, Korea and China
Completed
- Overactive Bladder (OAB)
- mirabegron
- +8 more
-
Daejeon, Korea, Republic of
- +14 more
Apr 21, 2020
Overactive Bladder (OAB) Trial in Canada, United States (Mirabegron, Tolterodine ER)
Completed
- Overactive Bladder (OAB)
- Mirabegron
- Tolterodine ER
-
Homewood, Alabama
- +29 more
Feb 17, 2020